Agonist effect on antigen

Industry

CPC
C07K2317/75

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K2317/00Immunoglobulins specific feautures

Current Industry

C07K2317/75Agonist effect on antigen

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Agonistic anti-tumor necrosis factor receptor 2 antibodies
- Patent number 12,269,891
- Issue date Apr 8, 2025
- The General Hospital Corporation
- Denise L. Faustman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-SIRPα antibodies and methods of use thereof
- Patent number 12,258,410
- Issue date Mar 25, 2025
- Alector LLC
- Andrew Pincetic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Adenovirus armed with bispecific T cell engager
- Patent number 12,258,417
- Issue date Mar 25, 2025
- AKAMIS BIO LIMITED
- Brian Robert Champion
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multispecific NK engager protein
- Patent number 12,252,543
- Issue date Mar 18, 2025
- Innate Pharma
- Laurent Gauthier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-transferrin receptor antibodies with tailored affinity
- Patent number 12,252,533
- Issue date Mar 18, 2025
- HOFFMANN-LA ROCHE INC.
- Stefan Dengl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules that bind CD137 and OX40
- Patent number 12,252,537
- Issue date Mar 18, 2025
- invoX Pharma Limited
- Mihriban Tuna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-SIRPa antibodies and their therapeutic applications
- Patent number 12,252,546
- Issue date Mar 18, 2025
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
BTN3A binding proteins and uses thereof
- Patent number 12,247,075
- Issue date Mar 11, 2025
- IMCHECK THERAPEUTICS SAS
- Alemseged Truneh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-DR5 antibodies and methods of use thereof
- Patent number 12,247,080
- Issue date Mar 11, 2025
- GENMAB B.V.
- Marije Overdijk
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-TREM2 antibodies and methods of use thereof
- Patent number 12,240,902
- Issue date Mar 4, 2025
- Denali Therapeutics Inc.
- Mark S. Dennis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engraftment of stem cells with a combination of an agent that targe...
- Patent number 12,233,093
- Issue date Feb 25, 2025
- The Board of Trustees of the Leland Stanford Junior University
- Judith A. Shizuru
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD137 agonist antibodies and uses thereof
- Patent number 12,227,582
- Issue date Feb 18, 2025
- QLSF BIOTHERAPEUTICS INC.
- Aaron Kurtzman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multivalent and multispecific OX40-binding fusion proteins
- Patent number 12,227,584
- Issue date Feb 18, 2025
- Inhibrx Biosciences, Inc.
- Brendan P. Eckelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-SIRP-alpha antibodies and methods of use thereof
- Patent number 12,226,482
- Issue date Feb 18, 2025
- ALECTOR LLC
- Andrew Pincetic
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of an immune checkpoint modulator and a complex compris...
- Patent number 12,214,048
- Issue date Feb 4, 2025
- AMAL THERAPEUTICS SA
- Madiha Derouazi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies to programmed cell death protein 1
- Patent number 12,209,127
- Issue date Jan 28, 2025
- Augusta University Research Institute, Inc.
- Samir Khleif
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies targeting CD137 and methods of use thereof
- Patent number 12,209,133
- Issue date Jan 28, 2025
- Numab Therapeutics AG
- Tea Gunde
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-4-1BB antibody and use thereof
- Patent number 12,195,537
- Issue date Jan 14, 2025
- ABL BIO, INC.
- Eunyoung Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to Tie-2 and methods of use
- Patent number 12,195,542
- Issue date Jan 14, 2025
- Unity Biotechnology, Inc.
- Jason Damiano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for making pluripotent stem cells
- Patent number 12,195,728
- Issue date Jan 14, 2025
- Minerva Biotechnologies Corporation
- Cynthia Bamdad
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PD-L1/anti-4-1BB bispecific antibodies and uses thereof
- Patent number 12,195,538
- Issue date Jan 14, 2025
- ABL Bio Inc.
- Eunyoung Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multivalent and multispecific 41BB-binding proteins
- Patent number 12,187,804
- Issue date Jan 7, 2025
- Inhibrx Biosciences, Inc.
- Brendan P. Eckelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD73 antibodies and use thereof
- Patent number 12,187,806
- Issue date Jan 7, 2025
- Development Center for Biotechnology
- Chun-Chung Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and t...
- Patent number 12,173,064
- Issue date Dec 24, 2024
- Janssen Biotech, Inc.
- Raluca Verona
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific polypeptides against CD137
- Patent number 12,173,082
- Issue date Dec 24, 2024
- Alligator Bioscience AB
- Eva Dahlén
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-c-Met agonist antibody and use thereof
- Patent number 12,173,074
- Issue date Dec 24, 2024
- Seoul National University R&DB Foundation
- Young Kee Shin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that bind CD3 epsilon
- Patent number 12,173,282
- Issue date Dec 24, 2024
- Twist Bioscience, Inc.
- Aaron Sato
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Polypeptide variants and uses thereof
- Patent number 12,173,076
- Issue date Dec 24, 2024
- GENMAB B.V.
- Frank Beurskens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-EGFR/anti-4-1BB bispecific antibody
- Patent number 12,168,690
- Issue date Dec 17, 2024
- ABL Bio Inc.
- Yeryoung Yong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combining CD27 agonists and immune checkpoint inhibition for immune...
- Patent number 12,168,693
- Issue date Dec 17, 2024
- ADURO BIOTECH HOLDINGS, EUROPE B.V.
- Hans Van Eenennaam
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
AGONISTIC ANTIBODIES THAT BIND CD40
- Publication number 20250115663
- Publication date Apr 10, 2025
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONIST FUSION PROTEIN FOR CD40 AND OX40 AND USES THEREOF
- Publication number 20250115673
- Publication date Apr 10, 2025
- Thomas Jefferson University
- Mark L. Tykocinski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE MODULATION OF BETA CHAIN-MEDIATED...
- Publication number 20250092134
- Publication date Mar 20, 2025
- JANSSEN BIOTECH, INC.
- Rajkumar Ganesan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-TREM1 Antibodies and Methods of Use Thereof
- Publication number 20250092131
- Publication date Mar 20, 2025
- ALECTOR LLC
- Andrew Pincetic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN ANTIBODIES TO PD-L1
- Publication number 20250092139
- Publication date Mar 20, 2025
- Regeneron Pharmaceuticals, Inc.
- Nicholas J. Papadopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION OR DRUG KIT FOR ALLEVIATING OR TREATING...
- Publication number 20250090523
- Publication date Mar 20, 2025
- Shanghai Synvida Biotechnology Co. Ltd.
- Junling LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VARIANT IgG FC POLYPEPTIDES AND USES THEREOF
- Publication number 20250074984
- Publication date Mar 6, 2025
- Seismic Therapeutic, Inc.
- Yen-Lin Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-EGFR/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF
- Publication number 20250066487
- Publication date Feb 27, 2025
- ABL Bio Inc.
- Yeryoung Yong
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TIGIT AND CD112R BLOCKADE
- Publication number 20250066470
- Publication date Feb 27, 2025
- Amgen Inc.
- Sue J. SOHN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS
- Publication number 20250066473
- Publication date Feb 27, 2025
- The Board of Trustees of the Leland Stanford Junior University
- Stephen Willingham
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONISTIC ANTI TNFR2 ANTIBODY MOLECULES
- Publication number 20250066492
- Publication date Feb 27, 2025
- BIOINVENT INTERNATIONAL AB
- Björn FRENDÉUS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD27 AGONISTS
- Publication number 20250059291
- Publication date Feb 20, 2025
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING HER2
- Publication number 20250059298
- Publication date Feb 20, 2025
- HOFFMANN-LA ROCHE INC.
- Stephan GASSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FAP/CD40 BINDING MOLECULE AND MEDICINAL USE THEREOF
- Publication number 20250051467
- Publication date Feb 13, 2025
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Yuan Lin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIGEN-BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR
- Publication number 20250051465
- Publication date Feb 13, 2025
- Regeneron Pharmaceuticals, Inc.
- Jesper GROMADA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTI-VEGF AND ANTI-TRKB BINDING MOLECULES FOR THE TREATM...
- Publication number 20250051460
- Publication date Feb 13, 2025
- Boehringer Ingelheim International GmbH
- Peter Michael BENZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3...
- Publication number 20250042999
- Publication date Feb 6, 2025
- Regeneron Pharmaceuticals, Inc.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LOW ENERGY IMMUNE PRIMING FOR TREATING CANCER AND METASTASIS
- Publication number 20250041631
- Publication date Feb 6, 2025
- Montefiore Medical Center
- Chandan GUHA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NON-CYTOTOXIC MODIFIED CELLS AND USE THEREOF
- Publication number 20250043000
- Publication date Feb 6, 2025
- THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD.
- Alon MONSONEGO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AGONISTIC LTBR ANTIBODIES AND BISPECIFIC ANTIBODIES COMPRISING THEM
- Publication number 20250034269
- Publication date Jan 30, 2025
- HOFFMANN-LA ROCHE INC.
- Roberta Bianchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF EFFECTING A HEMODYNAMIC CHANGE BY ADMINISTERING AN ANTI-...
- Publication number 20250034279
- Publication date Jan 30, 2025
- Regeneron Pharmaceuticals, Inc.
- Michael E. DUNN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-SIRP-Beta1 Antibodies and Methods of Use Thereof
- Publication number 20250026827
- Publication date Jan 23, 2025
- ALECTOR LLC
- Andrew Pincetic
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED PROTEIN OR POLYPEPTIDE
- Publication number 20250026842
- Publication date Jan 23, 2025
- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.
- Nan WANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY SUBSTITUTING FOR FUNCTION OF BLOOD COAGULATION FACTOR VIII
- Publication number 20250026854
- Publication date Jan 23, 2025
- Chugai SeiYaku Kabushiki Kaisha
- Kunihiro Hattori
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ADENOVIRUS ARMED WITH BISPECIFIC T CELL ACTIVATOR
- Publication number 20250026851
- Publication date Jan 23, 2025
- AKAMIS BIO LIMITED
- Brian Robert CHAMPION
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AGENTS THAT ENGAGE ANTIGEN-PRESENTING CELLS THROUGH DENDRITIC CELL...
- Publication number 20250018025
- Publication date Jan 16, 2025
- Baylor Research Institute
- SangKon OH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC AGONISTIC ANTIBODIES TO IL12 RECEPTOR
- Publication number 20250019450
- Publication date Jan 16, 2025
- DIAGONAL THERAPEUTICS INC.
- Alexey Alexandrovich Lugovskoy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Procoagulant Antibodies
- Publication number 20250011468
- Publication date Jan 9, 2025
- Novo Nordisk A/S
- Karina Thorn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DYSFUNCTIONAL ANTIGEN-SPECIFIC CD8+ T CELLS IN THE TUMOR MICROENVIR...
- Publication number 20250011452
- Publication date Jan 9, 2025
- The University of Chicago
- Thomas Gajewski
- G01 - MEASURING TESTING
Information Patent Application
WNT SIGNALING AGONIST MOLECULES
- Publication number 20250011437
- Publication date Jan 9, 2025
- The Board of Trustees of the Leland Stanford Junior University
- Kenan Christopher Garcia
- C07 - ORGANIC CHEMISTRY

Agonist effect on antigen

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Agonistic anti-tumor necrosis factor receptor 2 antibodies

Anti-SIRPα antibodies and methods of use thereof

Adenovirus armed with bispecific T cell engager

Multispecific NK engager protein

Anti-transferrin receptor antibodies with tailored affinity

Antibody molecules that bind CD137 and OX40

Anti-SIRPa antibodies and their therapeutic applications

BTN3A binding proteins and uses thereof

Anti-DR5 antibodies and methods of use thereof

Anti-TREM2 antibodies and methods of use thereof

Engraftment of stem cells with a combination of an agent that targe...

CD137 agonist antibodies and uses thereof

Multivalent and multispecific OX40-binding fusion proteins

Anti-SIRP-alpha antibodies and methods of use thereof

Combination of an immune checkpoint modulator and a complex compris...

Antibodies to programmed cell death protein 1

Antibodies targeting CD137 and methods of use thereof

Anti-4-1BB antibody and use thereof

Antibodies directed to Tie-2 and methods of use

Method for making pluripotent stem cells

Anti-PD-L1/anti-4-1BB bispecific antibodies and uses thereof

Multivalent and multispecific 41BB-binding proteins

Anti-CD73 antibodies and use thereof

Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and t...

Bispecific polypeptides against CD137

Anti-c-Met agonist antibody and use thereof

Antibodies that bind CD3 epsilon

Polypeptide variants and uses thereof

Anti-EGFR/anti-4-1BB bispecific antibody

Combining CD27 agonists and immune checkpoint inhibition for immune...

Patents Applicationslast 30 patents

AGONISTIC ANTIBODIES THAT BIND CD40

AGONIST FUSION PROTEIN FOR CD40 AND OX40 AND USES THEREOF

COMPOSITIONS AND METHODS FOR THE MODULATION OF BETA CHAIN-MEDIATED...

Anti-TREM1 Antibodies and Methods of Use Thereof

HUMAN ANTIBODIES TO PD-L1

PHARMACEUTICAL COMPOSITION OR DRUG KIT FOR ALLEVIATING OR TREATING...

VARIANT IgG FC POLYPEPTIDES AND USES THEREOF

ANTI-EGFR/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF

TIGIT AND CD112R BLOCKADE

TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS

AGONISTIC ANTI TNFR2 ANTIBODY MOLECULES

CD27 AGONISTS

AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING HER2

FAP/CD40 BINDING MOLECULE AND MEDICINAL USE THEREOF

ANTIGEN-BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR

BISPECIFIC ANTI-VEGF AND ANTI-TRKB BINDING MOLECULES FOR THE TREATM...

USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3...

LOW ENERGY IMMUNE PRIMING FOR TREATING CANCER AND METASTASIS

NON-CYTOTOXIC MODIFIED CELLS AND USE THEREOF

AGONISTIC LTBR ANTIBODIES AND BISPECIFIC ANTIBODIES COMPRISING THEM

METHODS OF EFFECTING A HEMODYNAMIC CHANGE BY ADMINISTERING AN ANTI-...

Anti-SIRP-Beta1 Antibodies and Methods of Use Thereof

MODIFIED PROTEIN OR POLYPEPTIDE

ANTIBODY SUBSTITUTING FOR FUNCTION OF BLOOD COAGULATION FACTOR VIII

ADENOVIRUS ARMED WITH BISPECIFIC T CELL ACTIVATOR

AGENTS THAT ENGAGE ANTIGEN-PRESENTING CELLS THROUGH DENDRITIC CELL...

BISPECIFIC AGONISTIC ANTIBODIES TO IL12 RECEPTOR

Procoagulant Antibodies

DYSFUNCTIONAL ANTIGEN-SPECIFIC CD8+ T CELLS IN THE TUMOR MICROENVIR...

WNT SIGNALING AGONIST MOLECULES